Alps Advisors Inc Avrobio, Inc. Transaction History

Alps Advisors Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$7.84 - $12.6 $587,952 - $944,924	-74,994 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$10.54 - $19.3 $96,177 - $176,112	9,125 Added 13.85%	74,994 $952,000
Q4 2020 Feb 03, 2021	BUY	$12.79 - $17.1 $248,125 - $331,740	19,400 Added 41.75%	65,869 $918,000
Q3 2020 Nov 04, 2020	SELL	$12.99 - $19.41 $34,917 - $52,174	-2,688 Reduced 5.47%	46,469 $605,000
Q2 2020 Aug 05, 2020	BUY	$12.19 - $22.96 $599,223 - $1.13 Million	49,157 New	49,157 $858,000

559K

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.